Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001459

CERILLIANT™ Hydroxyitraconazole, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001459 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-459 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-459 Supplier MilliporeSigma Supelco Supplier No. H1101ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Hydroxyitraconazole is an active metabolite of itraconazole, an antifungal drug used for the treatment of fungal infections. Therapeutic drug monitoring of hydroxyitraconazole is utilized in the management of patients receiving itraconazole to ensure therapeutic levels of the drug have been achieved. This Certified Spiking Solution™ is suitable as starting material for calibrators, controls, or linearity standards for therapeutic drug monitoring or clinical and diagnostic testing of hydroxyitraconazole in patient blood, serum, or plasma samples by HPLC or LC-MS/MS.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 112559-91-8
Linear Formula C35H38Cl2N8O5
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol
Formula Weight 721.63
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.